Hereditary muscular dystrophies and the heart

被引:126
作者
Hermans, M. C. E. [1 ]
Pinto, Y. M. [2 ]
Merkies, I. S. J. [1 ,3 ]
de Die-Smulders, C. E. M. [4 ]
Crijns, H. J. G. M. [5 ]
Faber, C. G. [1 ]
机构
[1] Maastricht Univ, Dept Neurol, Med Ctr, NL-6202 AZ Maastricht, Netherlands
[2] Acad Med Ctr Amsterdam, Dept Cardiol, Amsterdam, Netherlands
[3] Spaarne Hosp, Dept Neurol, Hoofddorp, Netherlands
[4] Maastricht Univ, Dept Clin Genet, Med Ctr, NL-6202 AZ Maastricht, Netherlands
[5] Maastricht Univ, Dept Cardiol, Med Ctr, NL-6202 AZ Maastricht, Netherlands
关键词
Muscular dystrophy; Cardiomyopathy; Arrhythmia; Sudden death; Treatment; LAMIN A/C GENE; LINKED DILATED CARDIOMYOPATHY; CAUSE AUTOSOMAL-DOMINANT; LEFT-VENTRICULAR DYSFUNCTION; PROXIMAL MYOTONIC MYOPATHY; SUDDEN CARDIAC DEATH; CLINICAL SPECTRUM; CONDUCTION-SYSTEM; SARCOGLYCAN GENE; NUCLEAR-MEMBRANE;
D O I
10.1016/j.nmd.2010.04.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cardiac disease is a common clinical manifestation of neuromuscular disorders, particularly of muscular dystrophies. Heart muscle cells as well as specialized conducting myocardial fibres may be affected by the dystrophic process. The incidence and nature of cardiac involvement vary with different types of muscular dystrophies. Some mainly lead to myocardial disease, resulting in cardiomyopathy and heart failure, while others particularly affect the conduction system, leading to arrhythmias and sudden death. As prognosis of muscular dystrophy patients may be directly related to cardiac status, surveillance and timely management of cardiac complications are important. However, recognition of cardiac involvement requires active investigation and remains challenging since typical signs and symptoms of cardiac dysfunction may not be present and progression is unpredictable. In this review, we present a comprehensive overview of hereditary muscular dystrophies associated with cardiac disease to provide an efficient strategy for the expertise and management of these diseases. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:479 / 492
页数:14
相关论文
共 174 条
[1]   Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin) [J].
Allamand, V ;
Guicheney, P .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (02) :91-94
[2]   The clinical spectrum of sarcoglycanopathies [J].
Angelini, C ;
Fanin, M ;
Freda, MP ;
Duggan, DJ ;
Siciliano, G ;
Hoffman, EP .
NEUROLOGY, 1999, 52 (01) :176-179
[3]   Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins:: A single shared haplotype indicates an ancestral founder effect [J].
Bachinski, LL ;
Udd, B ;
Meola, G ;
Sansone, V ;
Bassez, G ;
Eymard, B ;
Thornton, CA ;
Moxley, RT ;
Harper, PS ;
Rogers, MT ;
Jurkat-Rott, K ;
Lehmann-Horn, F ;
Wieser, T ;
Gamez, J ;
Navarro, C ;
Bottani, A ;
Kohler, A ;
Shriver, MD ;
Sallinen, R ;
Wessman, M ;
Zhang, SX ;
Wright, FA ;
Krahe, R .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (04) :835-848
[4]   Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration [J].
Bakay, M ;
Wang, ZY ;
Melcon, G ;
Schiltz, L ;
Xuan, JH ;
Zhao, P ;
Sartorelli, V ;
Seo, J ;
Pegoraro, E ;
Angelini, C ;
Shneiderman, B ;
Escolar, D ;
Chen, YW ;
Winokur, ST ;
Pachman, LM ;
Fan, CG ;
Mandler, R ;
Nevo, Y ;
Gordon, E ;
Zhu, YT ;
Dong, YB ;
Wang, Y ;
Hoffman, EP .
BRAIN, 2006, 129 :996-1013
[5]   Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: Immunohistochemical analysis and clinical aspects [J].
Barresi, R ;
Confalonieri, V ;
Lanfossi, M ;
DiBlasi, C ;
Torchiana, E ;
Mantegazza, R ;
Jarre, L ;
Nardocci, N ;
Boffi, P ;
Tezzon, F ;
Pini, A ;
Cornelio, F ;
Mora, M ;
Morandi, L .
ACTA NEUROPATHOLOGICA, 1997, 94 (01) :28-35
[6]   Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations [J].
Barresi, R ;
Di Blasi, C ;
Negri, T ;
Brugnoni, R ;
Vitali, A ;
Felisari, G ;
Salandi, A ;
Daniel, S ;
Cornelio, F ;
Morandi, L ;
Mora, M .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (02) :102-107
[7]   Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1 [J].
Bassez, G ;
Lazarus, A ;
Desguerre, I ;
Varin, J ;
Laforêt, P ;
Bécane, HM ;
Meune, C ;
Arne-Bes, MC ;
Ounnoughene, Z ;
Radvanyi, H ;
Eymard, B ;
Duboc, D .
NEUROLOGY, 2004, 63 (10) :1939-1941
[8]   Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy [J].
Bauer, Ralf ;
Straub, Volker ;
Blain, Alison ;
Bushby, Kate ;
MacGowan, Guy A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (05) :463-471
[9]   High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation [J].
Bécane, HM ;
Bonne, G ;
Varnous, S ;
Muchir, A ;
Ortega, V ;
Hammouda, E ;
Urtizberea, JA ;
Lavergne, T ;
Fardeau, M ;
Eymard, B ;
Weber, S ;
Schwartz, K ;
Duboc, D .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11) :1661-1666
[10]  
Beckmann J S, 1999, Neuromuscul Disord, V9, P436, DOI 10.1016/S0960-8966(99)00064-4